loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of suppliers providing reference standards related to DSSTox_CID_28917

    Client Email Product
    Menu

    DSSTox_CID_28917

    APIs // Active Pharmaceutical Ingredients

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Creative Peptides (1)

    filter

    01 90779-69-4 (1)

    filter

    01 Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban is indicated to delay imminent pre-term birth in pregnant adult women. Atosiban is useful in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). The pregnancy rate improved from zero to 43.7%. More information please visit the website: http://www.creative-peptides.com/product/atosib (1)

    filter

    01 U.S.A (1)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Creative Peptides

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Atosiban

      PDF Supplier PDF
      URL Supplier Web Content
      90779-69-4
      Atosiban is a nonapeptide...
      10-101-05
      Product List
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Post Enquiry
      POST ENQUIRY